Back to mobile site

Maze Therapeutics (MAZE) files mixed shelf

February 4, 2026 5:22 PM EST

Maze Therapeutics (NASDAQ: MAZE) has filed mixed shelf of:

Common Stock, Preferred Stock, Debt Securities, Warrants, Subscription Rights and Units




Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Equity Offerings

Related Entities

Maynard Um, Mark Zuckerberg, ARK